Transdermal Flashcards
What are the benefits of orally administering a compound?
Fast onset. Patient acceptance. Easy to manufacture. Large surface area. Rich blood supply.
What are the drawbacks of orally administering a compound?
Variability of absorption.
Adverse reactions.
Patient compliance issues from multiple daily dosing.
Peaks and toughs.
Side effects due to peaks, sub-therapeutic effect due to troughs,
How does oral and transdermal drug delivery differ in terms of the biological carrier?
GIT vs stratum corneum.
Low barrier resistance vs highly impermeable barrier.
Variable pH bs acidic lipid barrier.
How does oral and transdermal drug delivery differ in terms of the formulation/delivery technology?
Tablets, capsules vs patches,
Powder technology vs polymer science.
Compression and coating methods vs films, webs, adhesives.
How does oral and transdermal drug delivery differ in terms of drug delivery efficiency and timing?
Payload completely delivered (ideally) vs typically less then 50% delivered by TDD.
6-18hr release/delivery vs. 0.5-7 days.
Variable surface area vs fixed area of delivery.
What are the benefits of transdermal drug administration? [8]
- Blood level plasma profiles are distinct from oral dosing: avoidance of “peaks and valleys”
- Different patch technologies are capable of equivalent and effective drug delivery.
- Dose titration is possible by changing patch area.
- 1st pass effect avoidance leads to altered metabolite levels etc.
- Application to diverse therapeutic areas.
- sustained delivery from 0.5-7 days.
- Can be used to deliver difficult to formulate drugs;
- Improved patient compliance and drug utilisation (reduced multiple daily dosing etc.)
What is an adhesive transdermal patch?
Simply a backing layer over a layer containing a mixture of adhesive compounds and the drug itself.
What is a layered patch?
Backing layer.
Polymer/Drug matrix layer.
Adhesive/Drug layer.
What is a reservoir patch?
Backing layer.
Drug reservoir.
Rate controlling membrane.
Adhesive/drug layer.
What is flip-flop kinetics?
Iv infusion: when pump is stopped the only process controlling drug elimination is the rate of systemic clearance.
For patches, absorption across the skin is the rate-limiting step and therefore even though the patch has been removed there is still drug being absorbed across the skin into the plasma.
What is the greatest limitation of transdermal drug delivery?
The potency of the drug.
What are 4 reasons we may wish to use topical drug delivery?
- Modulate barrier function.
- Treat disease states in the epidermis and dermis.
- Alleviate local pain/inflammation in subcutaneous tissues.
- Elicit systemic pharmacological effect.
What are the sequential steps in the percutaneous absorption of a drug? [3]
- Drug is applied in vehicle/formulation in which it must diffuse to the skin surface, be released and partition across the SC.
- Drug diffuses across SC, reaching interface with the underlying viable epidermis where the drug must partition into this more aqueous in nature tissue.
- The drug diffuses through the viable skin until encountering the microcirculation where it is resorbed into the blood and eventually conveyed to the central compartment.
Why do lipophilic drugs penetrate the skin relatively poorly?
Lipophilic drugs partition avidly into the SC they then leave this ‘sympathetic’ environment for the more aqueous in nature viable epidermis only reluctantly. The ‘phase transfer’ from the SC into epidermis becomes the rate-limiting step for these drugs.
Which part of the skin represents the principal barrier to topical and transdermal drug delivery?
The stratum corneum
Describe the composition of the stratum corneum.
Bricks (dead-keratin filled cells) + mortar (complex lipid mixture: ceramides, cholesterol, free fatty acids).
Rivets in the mortar which hold corneocytes together are specialised protein structures known as corneodesmosomes.
What are corneodesmosomes.
Rivets in the mortar which hold corneocytes together are specialised protein structures known as corneodesmosomes.
They are the major structures to be degraded during desquamation of the skin.
What is the ‘mortar’ in the SC composed of?
Complex mixture of lipids: ceramides, free fatty acids, cholesterol.
How thick is the SC? What impact does this have on drug transit?
~10micometers.
Not that much of an impact as the principal route of drug transit is inter/paracellularly so the pathlength is much greater than SC thickness.
What is the rationale behind using topical drug delivery to treat local, subcutaneous pain and inflammation?
- ‘outside-in’ is at least as effective as ‘inside-out’.
- Significantly less systemic exposure and GI disturbances.
- Similar if not better plasma profiles achieved.
What are the two parameters that can be varied by a formulation scientist to maximise topical flux?
Drug concentration in the vehicle.
Partition coefficient of the drug between the SC and the vehicle.